Recombinant SARS-CoV-2 Spike (Cilgavimab Biosimilar) antibody
The Human Monoclonal anti-SARS-CoV-2 Spike (Cilgavimab Biosimilar) antibody (ABIN7813233) specifically detects SARS-CoV-2 Spike (Cilgavimab Biosimilar).
The antibody is reactive with SARS Coronavirus-2 (SARS-CoV-2) samples.
Catalog No. ABIN7813233
$605.00
Plus shipping costs $50.00
100 μg
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant SARS-CoV-2 Spike (Cilgavimab Biosimilar) antibody (ABIN7813233)
Target
SARS-CoV-2 Spike (Cilgavimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
SARS Coronavirus-2 (SARS-CoV-2)
Host
Human
Clonality
Monoclonal
Conjugate
Un-conjugated
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Cilgavimab Biosimilar - Anti-RBD mAb - Research Grade
-
Characteristics
- IgG1, kappa
-
Isotype
- IgG1, kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4.
-
Handling Advice
- Avoid repeated freeze-thaw cycles
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- 4°C for short term (1 week), store at -20°C to -80°C for long term(1 year), Avoid repeated freeze-thaw cycles
-
Expiry Date
- 12 months
-
-
- SARS-CoV-2 Spike (Cilgavimab Biosimilar)
-
Alternative Name
- Cilgavimab Biosimilar
-
Target Type
- Biosimilar
-
Background
- Anti-Spike Protein, Anti-RBD
-
UniProt
- P0DTC2
Target
-
You are here:
